603456 Zhejiang Jiuzhou Pharmaceutical
- 15.11
- +0.39+2.65%
Zhejiang Jiuzhou Pharmaceutical News
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2024 First Quarter Report
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on holding a performance briefing for the first quarter of 2024
Zhejiang Jiuzhou Pharmaceutical Co., Ltd.'s progress announcement on the establishment of a Japanese wholly-owned subsidiary
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Investor Relations Activity Record Form 20240409
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. Fund Raising Management System (Revised in April 2024)
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (Yu Biao)
Report of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the performance of supervisory duties of the company's audit committee on accounting firms in 2023
Notice of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on convening the 2023 Annual General Meeting of Shareholders
2023 Audit Report
Summary of the 2023 Annual Report of Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (Kong Delan)
Zhejiang Jiuzhou Pharmaceutical Internal Control Audit Report
Huatai United Securities Co., Ltd. annual report on the continuous supervision of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. in 2023
Special opinion of the board of directors of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the independence of independent directors
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. report on the company\'s 2023 evaluation of the performance of accounting firms
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on changes in accounting policies
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2023 Independent Director Debriefing Report (Li Jicheng)
Announcement of Zhejiang Jiuzhou Pharmaceutical Co., Ltd. on the company\'s application for bank credit with its own assets
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2023 Annual Report
Zhejiang Jiuzhou Pharmaceutical Co., Ltd. 2023 Internal Control Evaluation Report
Analysis
Price Target
No Data
